Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: J Physiol. 2022 Dec 11;601(3):451–467. doi: 10.1113/JP283208

Table 2.

Vessel outer diameter at baseline, with PE, flow (45 ul/min), and with ACh (10−3 M)

Group and treatment Baseline Outer diameter Outer diameter with PE (10−6 to 10−4 M) Outer diameter with Flow (45 ul/min) Outer diameter with ACh (10−3 M)
Young 306±105 263±92 292±101 302±104
Young + ML090 307±104 261±94 292±99 301±99
Young + gp91 304±100 264±93 292±101 309±107
Young + plumbagin 304±100 264±92 293±100 295±88
Middle aged 308±115 271±18 285±110 294±99
Middle aged + ML090 306±64 267±67 286±67 294±98
Middle aged + gp91 296±98 261±89 289±94 307±101
Middle + plumbagin 308±84 268±88 287±84 298±97
Old 302±61 270±61 275±60 285±108
Old + ML090 302±53 268±55 278±54 285±115
Old + gp91 300±77 262±79 287±80 306±113
Old + plumbagin 298±52 264±52 279±51 300±111

Vessel characteristics. Vessel outer diameter (μm) at baseline (intraluminal pressure ≈60 mmHg), incubation with phenylephrine (PE) (10−6 to 10−4 M), with Flow(45 ul/min), and with acetylcholine (ACh) (10−3 M). Data are expressed as mean ± SD.